The Manila Times

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 ...